跳至主要内容
临床试验/EUCTR2016-002015-17-DK
EUCTR2016-002015-17-DK进行中(未招募)1 期

ow-flow Low-gradient Aortic Stenosis – Diagnostic Usefullness of Ivabradine

Odense University Hospital0 个研究点目标入组 25 人开始时间: 2016年9月2日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
25

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • Inclusion criteria
  • 1.Low-flow (SV index<35 ml/m2) low-gradient (meangradient <40 mmHg) AS with AVA<1,0 cm2
  • 2.Age > 18 years
  • 3.Signed informed consent
  • 4.Heart rate > 60 beats per minute
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 15
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 10

排除标准

  • 1.Other moderate-severe valvular heart disease other than AS
  • 2.Unwilling to participate in the study
  • 3.Mental disorder precluding informed consent
  • 4.Poor echocardiographic window
  • 5.Chronic atrial fibrillation
  • 6.Sinus node dysfunction
  • 7.Bradycardia < 60 BPM
  • 8.Complete AV block or permanent cardiac pacemaker
  • 9.Hypotension <90/50 mmHg
  • 10.Concomitant treatment with diltiazem or verapamil
  • 11.Liver dysfunction with ALAT twice upper limit of normal.
  • 12. Pregnancy

研究者

相似试验